65 Days
المصدر:
الصحة والعلوم الشرق الأوسط
المصدر: الصحة والعلوم الشرق الأوسط
65 Daysالصحة والعلوم الشرق الأوسط
المصدر: الصحة والعلوم الشرق الأوسط
65 Daysجاهز للتشغيل
جاهز للتشغيل
A study has found that long-term use of GLP-1 medications by patients with type 2 diabetes increases the risk of experiencing smell and taste disorders. The incidence rates rose by 81% for smell and 52% for taste compared to patients using other medications. The results also showed that the actual rates of these sensory disorders were very low, with 0.37% among users and 0.22% among non-users. The researchers emphasized the importance of more precise health monitoring and analyzing the mechanisms behind this relationship.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading